• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Hypersensitivity pneumonitis in Covid-19: mortality, risk factors, and clinical outcomes from a 30-case observational study.

作者信息

Ozgun Niksarlioglu Elif Yelda, Uysal Mehmet Atilla, Seyhan Ekrem Cengiz, Kıyık Murat, Çetinkaya Erdoğan

机构信息

Health Science University, Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, Department of Chest Diseases, Istanbul, Turkey.

出版信息

Sarcoidosis Vasc Diffuse Lung Dis. 2025 Mar 18;42(1):16163. doi: 10.36141/svdld.v42i1.16163.

DOI:10.36141/svdld.v42i1.16163
PMID:40100115
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12013693/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd2b/12013693/b9f0951e44bb/SVDLD-42-16163-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd2b/12013693/b9f0951e44bb/SVDLD-42-16163-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd2b/12013693/b9f0951e44bb/SVDLD-42-16163-g001.jpg

相似文献

1
Hypersensitivity pneumonitis in Covid-19: mortality, risk factors, and clinical outcomes from a 30-case observational study.新冠病毒病中的过敏性肺炎：一项30例观察性研究的死亡率、危险因素及临床结局
Sarcoidosis Vasc Diffuse Lung Dis. 2025 Mar 18;42(1):16163. doi: 10.36141/svdld.v42i1.16163.
2
The MUC5B promoter polymorphism and telomere length in patients with chronic hypersensitivity pneumonitis: an observational cohort-control study.慢性过敏性肺炎患者的 MUC5B 启动子多态性和端粒长度：一项观察性队列对照研究。
Lancet Respir Med. 2017 Aug;5(8):639-647. doi: 10.1016/S2213-2600(17)30216-3. Epub 2017 Jun 22.
3
When to panic about a panic attack: A challenging case of hypersensitivity pneumonitis.何时对惊恐发作感到恐慌：一例过敏性肺炎的挑战性病例。
Paediatr Respir Rev. 2023 Dec;48:20-23. doi: 10.1016/j.prrv.2023.05.002. Epub 2023 May 9.
4
Chronic hypersensitivity pneumonitis in patients diagnosed with idiopathic pulmonary fibrosis: a prospective case-cohort study.特发性肺纤维化患者的慢性过敏性肺炎：一项前瞻性病例队列研究。
Lancet Respir Med. 2013 Nov;1(9):685-94. doi: 10.1016/S2213-2600(13)70191-7. Epub 2013 Oct 21.
5
Epidemiology of Hypersensitivity Pneumonitis among an Insured Population in the United States: A Claims-based Cohort Analysis.美国保险人群中过敏性肺炎的流行病学：基于理赔的队列分析。
Ann Am Thorac Soc. 2018 Apr;15(4):460-469. doi: 10.1513/AnnalsATS.201704-288OC.
6
A major genetic determinant of autoimmune diseases is associated with the presence of autoantibodies in hypersensitivity pneumonitis.自身免疫性疾病的一个主要遗传决定因素与过敏性肺炎中自身抗体的存在有关。
Eur Respir J. 2020 Aug 13;56(2). doi: 10.1183/13993003.01380-2019. Print 2020 Aug.
7
A case of hypersensitivity pneumonitis with giant cells in a female dental technician.一名女性牙科技术员患伴有巨细胞的过敏性肺炎病例。
Ann Occup Environ Med. 2013 Oct 4;25(1):19. doi: 10.1186/2052-4374-25-19.
8
Chronic hypersensitivity pneumonitis is associated with an increased risk of venous thromboembolism: a retrospective cohort study.慢性过敏性肺炎与静脉血栓栓塞风险增加相关：一项回顾性队列研究。
BMC Pulm Med. 2021 Dec 17;21(1):416. doi: 10.1186/s12890-021-01794-y.
9
Hypersensitivity pneumonitis reaction to Mycobacterium avium in household water.家庭用水中鸟分枝杆菌引起的超敏性肺炎反应
Chest. 2005 Feb;127(2):664-71. doi: 10.1378/chest.127.2.664.
10
An update on hypersensitivity pneumonitis: what a clinician wants to know.过敏性肺炎的最新进展：临床医生想了解的内容。
Curr Opin Pulm Med. 2021 Mar 1;27(2):95-104. doi: 10.1097/MCP.0000000000000763.

本文引用的文献

1
Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients.COVID-19 相关死亡风险因素：42 项研究和 423117 例患者的系统评价和荟萃分析。
BMC Infect Dis. 2021 Aug 21;21(1):855. doi: 10.1186/s12879-021-06536-3.
2
Interstitial lung disease increases susceptibility to and severity of COVID-19.间质性肺疾病增加了感染 COVID-19 的易感性和严重程度。
Eur Respir J. 2021 Dec 2;58(6). doi: 10.1183/13993003.04125-2020. Print 2021 Dec.
3
Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study.
间质性肺疾病患者 COVID-19 住院治疗结局。一项国际多中心研究。
Am J Respir Crit Care Med. 2020 Dec 15;202(12):1656-1665. doi: 10.1164/rccm.202007-2794OC.
4
Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial.地塞米松对中重度 COVID-19 相关急性呼吸窘迫综合征患者存活天数和无呼吸机天数的影响：CoDEX 随机临床试验。
JAMA. 2020 Oct 6;324(13):1307-1316. doi: 10.1001/jama.2020.17021.
5
Dexamethasone in Hospitalized Patients with Covid-19.地塞米松在 COVID-19 住院患者中的应用。
N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.
6
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.中国武汉严重 COVID-19 患者的临床病程和结局：一项单中心、回顾性、观察性研究。
Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24.